Indaptus Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | $3.2M | — |
| Mar 2020 | — | $2.7M | — |
| Jun 2020 | — | $2.0M | $13.8M |
| Sep 2020 | — | $513 | — |
| Dec 2020 | — | $-237.7K | $1.6M |
| Mar 2021 | — | $-829.7K | — |
| Jun 2021 | — | $-1.3M | $17.0M |
| Sep 2021 | — | $38.1M | $41.9M |
| Dec 2021 | — | $35.9M | $39.1M |
| Mar 2022 | — | $33.4M | $33.2M |
| Jun 2022 | — | $30.4M | $14.3M |
| Sep 2022 | — | $27.6M | $6.7M |
| Dec 2022 | — | $24.6M | $9.6M |
| Mar 2023 | — | $21.2M | $6.8M |
| Jun 2023 | — | $18.6M | $12.7M |
| Sep 2023 | — | $15.3M | $16.0M |
| Dec 2023 | — | $12.1M | $13.4M |
| Mar 2024 | — | $9.4M | $9.7M |
| Jun 2024 | — | $6.2M | $7.3M |
| Sep 2024 | — | $6.0M | $7.4M |
| Dec 2024 | — | $3.9M | $5.8M |
| Mar 2025 | — | $2.8M | $3.9M |
| Jun 2025 | — | $-1.7M | $6.2M |
| Sep 2025 | — | $4.6M | $5.8M |
| Dec 2025 | — | $3.2M | $8.5M |
| Mar 2026 | — | $1.2M | $1.5M |
| Jun 2026 | — | $11.4M | $7.6M |